FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to a new non-pathogenic strain LEV82 of human Enterovirus A, Coxsackie serotype A7, deposited in the State collection of viruses under number 3028.
EFFECT: invention is used for non-specific prevention of viral infections, particularly emergency non-specific prevention of viral infections and treatment of oncological diseases.
1 cl, 11 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF ENTEROVIRUS COXSACKIE B6 SELECTIVELY INFECTING AND LYSING TUMOROUS HUMAN CELLS in vitro | 2012 |
|
RU2496873C1 |
| STRAIN OF ENTEROVIRUS A71 OF SUBGENOTYPE TYPE C4 USED FOR DIAGNOSTICS AND STUDY OF EFFICIENCY OF MEDICAL AND PREVENTIVE AND VACCINAL PREPARATIONS | 2014 |
|
RU2565811C1 |
| METHOD FOR CULTIVATION OF FETAL PORCINE CELLS FOR VIROLOGY | 2021 |
|
RU2795135C2 |
| ANTIVIRAL COMPOUND OF MULTIPLE ACTION, ITS COMPOSITION AND METHOD OF TREATING VIRAL DISEASES | 2012 |
|
RU2597150C2 |
| USING COMPOUNDS OF ANTIVIRAL CLASS FOR PREPARING AGENT FOR TREATMENT AND PROPHYLAXIS OF RESPIRATORY TRACT VIRAL INFECTION | 2002 |
|
RU2301669C2 |
| ASSOCIATED VACCINE AGAINST CANINE DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION OF DOGS | 2022 |
|
RU2806164C1 |
| STRAIN OF RE-GRAFTEDCELLS HEP-2-KD USED FOR VIROLOGICAL INVESTIGATIONS | 0 |
|
SU1122693A1 |
| STRAIN OF EBOL VIRUS "ZAIR CH-5" FOR CARRYING OUT MODEL EXPERIMENTS AND PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2001 |
|
RU2225440C2 |
| ANTI-TUMOUR AGENT BASED ON RECOMBINANT VACCINIA VIRUS STRAIN AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2730657C1 |
| ALTERNATED STRAIN OF MODIFIED VACCINIA VIRUS ANKARA (MVA) | 2001 |
|
RU2280075C2 |
